
Tina Smith Stock Trades
U.S. Senator · D · MN
Disclosures through May 10
Every stock trade Tina Smith has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.
Sample · the intelligence layer
Tina Smith · Sold $DXCM · May 7 · $100K–$250K
2 other members traded this name in the same window.
Coldpine’s read
Smith's Finance Committee seat carries jurisdiction over healthcare and Medicare policy that touches medical-device makers like DexCom. The spouse-owned sale of $100K–$250K clears at the higher end of typical disclosed ranges. Two other members sold DXCM in the same direction within 30 days, and the 3-day disclosure lag means the market has had limited time to absorb the filing.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Tina Smith
Get an email the moment Tina Smith discloses a new trade. Free, no card, no spam.
Most-traded tickers
Recent filingsAll filings, newest first
- Periodic transaction report, May 10, 20264 trades · DXCM, PODD
- Periodic transaction report, Apr 2, 20262 trades · BRK.B, MMM
- Periodic transaction report, Jan 30, 20262 trades · BRK.B
Recent disclosed trades
| Date | Ticker | Asset | Type | Amount |
|---|---|---|---|---|
| May 7 | DXCMDXCMDexCom, Inc. - Common Stock | DexCom, Inc. - Common Stock | sell | $100K–$250K |
| May 7 | PODDPODDInsulet Corporation - Common Stock | Insulet Corporation - Common Stock | sell | $100K–$250K |
| Apr 29 | DXCMDXCMDexCom, Inc. - Common Stock | DexCom, Inc. - Common Stock | sell | $100K–$250K |
| Apr 29 | PODDPODDInsulet Corporation - Common Stock | Insulet Corporation - Common Stock | sell | $100K–$250K |
| Mar 31 | BRK.BBRK.BBerkshire Hathaway Inc. New Common Stock | Berkshire Hathaway Inc. New Common Stock | sell | $100K–$250K |
| Mar 31 | MMMMMM3M Company Common Stock | 3M Company Common Stock | sell | $50K–$100K |
| Jan 27 | — | MRSH - Marsh & McLennan Companies, Inc. Common Stock | sell | $50K–$100K |
| Jan 27 | BRK.BBRK.BBerkshire Hathaway Cl B | Berkshire Hathaway Cl B | sell | $100K–$250K |
From Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →